Related Experiment Video
Updated: Aug 19, 2026
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
Macrophage antitumor activity: impaired responsiveness to interferon-gamma of macrophages from genetically defective
Abstract:
Macrophages (M phi) from the genetically defective mouse strains C3H/HeJ, A/J and P/J were unable to develop high levels of antitumor activities when stimulated either with immune recombinant interferon gamma (IFN-gamma) or with nonimmune IFN-alpha and IFN-beta, as compared to M phi or normal C3H/HeN mice. IFN-gamma appeared to be an exceptionally good activator of C3H/HeN M phi, as it could induce tumoricidal capacities 3000 times more efficiently than nonimmune IFN. The high efficiency of IFN-gamma as M phi activator was indeed confirmed on defective M phi. In fact, at high doses IFN-gamma could also induce significant levels of both cytolytic and cytostatic activity in M phi of A/J and P/J mice, although it could not increase cytotoxic activities of C3H/HeJ M phi.
Insights
Genetically defective macrophages showed reduced antitumor activity. However, high doses of interferon-gamma (IFN-gamma) partially restored these activities in some defective mouse strains, highlighting IFN-gamma
Area of Science:
- Immunology
- Cell Biology
- Genetics
Background:
- Macrophages (M phi) are crucial immune cells involved in antitumor responses.
- Genetic defects can impair macrophage function and antitumor capabilities.
- Interferons (IFNs) are cytokines known to modulate immune cell activity.
Purpose of the Study:
- To investigate the antitumor activity of macrophages from genetically defective mouse strains.
- To compare the efficacy of different interferon types (IFN-gamma, IFN-alpha, IFN-beta) in activating these macrophages.
- To determine the role of interferon-gamma (IFN-gamma) as a macrophage activator in both normal and defective strains.
Main Methods:
- Isolation and stimulation of macrophages from C3H/HeJ, A/J, P/J (defective) and C3H/HeN (normal) mouse strains.
- Treatment of macrophages with immune recombinant interferon gamma (IFN-gamma), nonimmune IFN-alpha, and IFN-beta.
- Assessment of macrophage antitumor activities, including cytolytic and cytostatic capacities.
Main Results:
- Macrophages from defective mouse strains exhibited lower antitumor activities compared to normal mice.
- IFN-gamma was a highly potent activator of normal C3H/HeN macrophages, inducing tumoricidal capacities significantly more efficiently than nonimmune IFNs.
- High doses of IFN-gamma restored significant cytolytic and cytostatic activities in macrophages from A/J and P/J mice, but not C3H/HeJ mice.
Conclusions:
- Genetic background significantly influences macrophage responsiveness to interferon stimulation.
- IFN-gamma is a potent activator of macrophage antitumor functions, with varying efficacy depending on the genetic defect.
- Targeted use of IFN-gamma may offer therapeutic potential for enhancing macrophage-mediated antitumor immunity in specific genetic contexts.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019